116 related articles for article (PubMed ID: 86635)
1. Effect of Propionibacterium acnes on the cellular immune responses to tumor-specific antigens on malignant rat liver cells.
Yokota T; Katahira S; Konno K; Minami K
J Natl Cancer Inst; 1979 Jun; 62(6):1511-5. PubMed ID: 86635
[TBL] [Abstract][Full Text] [Related]
2. Propionibacterium acnes-mediated humoral immune responses to tumor-specific antigens on rat liver cells transformed in vitro by chemical carcinogens.
Yokota T; Katahira S; Konno K; Minami K
J Natl Cancer Inst; 1978 Dec; 61(6):1525-9. PubMed ID: 281560
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor lymph node cells from mice bearing methylcholanthrene-induced sarcomas.
Indrová M; Bubeník J
Neoplasma; 1979; 26(4):405-12. PubMed ID: 160510
[TBL] [Abstract][Full Text] [Related]
4. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
Germain RN; Williams RM; Benacerraf B
Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
[TBL] [Abstract][Full Text] [Related]
5. Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens.
Rao VS; Bonavida B
Cancer Res; 1976 Apr; 36(4):1384-91. PubMed ID: 56998
[TBL] [Abstract][Full Text] [Related]
6. Role of T-cell subsets in the destruction of established metastases of 13762A rat mammary adenocarcinoma.
Howell LE; Kreider JW; Bartlett GL
J Natl Cancer Inst; 1986 Jul; 77(1):187-93. PubMed ID: 3487670
[TBL] [Abstract][Full Text] [Related]
7. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
Weinhold KJ; Wheelock EF
Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
9. Immunologic studies of prostatic cancer using the R3327 rat model.
Lubaroff DM; Reynolds CW; Culp DA
Trans Am Assoc Genitourin Surg; 1978; 70():60-5. PubMed ID: 753024
[TBL] [Abstract][Full Text] [Related]
10. Generation of cytotoxic lymphocytes against human tumor cells in vitro by various soluble microbial extracts.
Sharma B; Brunda MJ; Minden P
J Natl Cancer Inst; 1979 Aug; 63(2):341-6. PubMed ID: 222929
[No Abstract] [Full Text] [Related]
11. Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice: major NKT cell recruitment and increased cytotoxicity.
Ananias RZ; Rodrigues EG; Braga EG; Squaiella CC; Mussalem JS; Longhini AL; Travassos LR; Longo-Maugéri IM
Scand J Immunol; 2007 Jun; 65(6):538-48. PubMed ID: 17523946
[TBL] [Abstract][Full Text] [Related]
12. Specific stimulatory and cytotoxic effects of lymphocytes sensitized in vitro to either alloantigens or tumor antigens.
Kall MA; Hellström I
J Immunol; 1975 Mar; 114(3):1083-8. PubMed ID: 1112984
[TBL] [Abstract][Full Text] [Related]
13. Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity.
Shu SY; Chou T; Sakai K
J Immunol; 1989 Jul; 143(2):740-8. PubMed ID: 2738408
[TBL] [Abstract][Full Text] [Related]
14. Rat cytotoxic T lymphocytes against human T-lymphotropic virus type 1-infected cells recognize gag gene and env gene encoded antigens.
Noguchi Y; Tateno M; Kondo N; Yoshiki T; Shida H; Nakayama E; Shiku H
J Immunol; 1989 Dec; 143(11):3737-42. PubMed ID: 2479689
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific antigens on rat liver cells transformed in vitro by chemical carcinogens.
Yokota T; Sizaret P; Martel N
J Natl Cancer Inst; 1978 Jan; 60(1):125-9. PubMed ID: 75266
[TBL] [Abstract][Full Text] [Related]
16. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
[TBL] [Abstract][Full Text] [Related]
17. Specific Schistosoma mansoni rat T cell clones. I. Generation and functional analysis in vitro and in vivo.
Pestel J; Dissous C; Dessaint JP; Louis J; Engers H; Capron A
J Immunol; 1985 Jun; 134(6):4132-9. PubMed ID: 2580907
[TBL] [Abstract][Full Text] [Related]
18. Differential ability of tumor-unique and cross-reactive antigen(s) on two murine hepatoma cell lines to induce Lyt-1+2- T cells responsible for in vivo protective immunity.
Shima J; Yoshioka T; Kosugi A; Ogata M; Fujiwara H; Hamaoka T; Ueda S; Kato S
Biken J; 1987 Mar; 30(1):1-8. PubMed ID: 2445335
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response.
Key ME; Hanna MG
J Natl Cancer Inst; 1981 Oct; 67(4):853-61. PubMed ID: 6944552
[TBL] [Abstract][Full Text] [Related]
20. Microcytotoxicity assay of immune responses to non-mammary tumor virus-induced, preneoplastic, and neoplastic mammary lesions in BALB/c mice.
Heppner GH; Kopp JS; Medina D
Cancer Res; 1976 Feb; 36(2 pt 2):753-8. PubMed ID: 1253160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
